Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Sarcoma × Doxorubicin × Clear all

Phase

Phase 2 62 Phase 1 27 Phase 3 25 Phase 1/2 13 Phase NA 8 Phase 2/3 3 Phase EARLY_PHASE1 2 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 10 Breast Neoplasms 3 Neoplasm, Residual 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Burkitt Lymphoma 2 Wilms Tumor 1 Subcutaneous panniculitis-like T-cell lymphoma 1 Sarcoma 1 Rhabdomyosarcoma 1 Obesity 1 Non-Muscle Invasive Bladder Neoplasms 1 Mediastinal Neoplasms 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Liver Neoplasms 1 Immunoblastic Lymphadenopathy 1 Hodgkin Disease 1 Enteropathy-Associated T-Cell Lymphoma 1 Carcinoma, Hepatocellular 1 Body Weight 1

Interventions

anlotinib 1 Tranexamic Acid 1 Indocyanine Green 1 Ifosfamide 1 Hyperbaric Oxygenation 1 Enoxaparin 1 Doxorubicin 1 Brachytherapy 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03514381 2026-04-14

IPIAP-STM

Institut Claudius Regaud

Phase 4 Completed

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡